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Bulk encapsulation of (coated or hydrophobic) nanoparticle aggregates into vesicles is possible 3 
by a simple lamellar-to-vesicle phase transition above pH 4 and using only a pH-responsive 4 
microbial glucolipid. Nanoparticle dispersion is assisted by sonication and the encapsulation 5 
spontaneously occurs in bulk water, without solvents. The approach does not require the use of 6 
phospholipids. The process is developed with magnetic iron oxide nanoparticles to form 7 
magnetoliposomes but it is extended to the encapsulation of upconverting nanoparticles with 8 
an average encapsulation efficiency of 60%. 9 
  10 
g-Fe2O3; NaF4:Yb/Ln
(Ln= Er or Tm) 
Microbial 
glucolipid
pH <4 4 < pH < 7
sonication
pH≥ 9
micelles
Nanoparticles water
Lamellar phase Vesicle phase
Encapsulation
uncoated
hydrophobic
or
 2 
Easy formation of functional liposomes in water using a 11 
pH-responsive microbial glycolipid: encapsulation of 12 
magnetic and up-converting nanoparticles 13 
Dr. Lisa Van Renterghem,a Dr. Fabrizio Guzzetta,b Patrick Le Griel,c Mohamed 14 
Selmane,c Dr. Ghazi Ben Messaoud,c Tabitha Tan Su Teng,d Prof. Sierin Lim,d Prof. Wim 15 
Soetaert,a,e Dr. Sophie Roelants,a,e Dr. Beatriz Julián-López,b Dr. Niki Baccilec,* 16 
 17 
a - InBio – Center for Industrial Biotechnology and Biocatalysis, Department of Biotechnology 18 
Faculty of Bioscience Engineering, Ghent University  19 
b - Institute of Advanced Materials (INAM), Universitat Jaume I, Avda. Sos Baynat s/n, 12071 20 
Castellón, Spain 21 
c - Sorbonne Universités, CNRS, Collège de France, Chimie de la Matière Condensée de Paris 22 
UMR 7574, 4, Place Jussieu, 75005 Paris, France 23 
d - School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 24 
Nanyang Dr., Singapore 637457, Singapore 25 
e - Bio Base Europe Pilot Plant, Rodenhuizekaai 1, 9042 Gent, Belgium 26 
 27 
Corresponding author: niki.baccile@upmc.fr 28 
 29 
Abstract 30 
The compartmentalization of colloids into topologically closed, vesicular, microphases offers 31 
an attractive mean to concentrate a functional cargo in aqueous solutions for a range of 32 
biomedical, cosmetic, and biotechnological applications. In this paper, we develop a simple, 33 
phospholipid-free, phase change method employing a pH-responsive glycolipid. The method is 34 
applied to the encapsulation of a sonicated, metastable, aqueous dispersion of functional 35 
colloids in the lumen of lipid vesicles: uncoated magnetic maghemite g-Fe2O3 and oleic-acid 36 
coated upconverting NaYF4:Yb/Ln (Ln= Er or Tm) nanoparticles (NPs). We find a stable 37 
liposomal dispersion containing a sub-population of crowded liposomes with high 38 
concentrations of NPs. The encapsulated NPs, formed at nearly neutral pH and room 39 
temperature, are stable over time and towards extrusion. The vesicular microphase is entirely 40 
composed of pH-responsive glycolipids, which undergo a pH-mediated mesoscopic structural 41 
transition from an open lamellar (2 < pH < 4) to topologically closed vesicular state (pH > 4). 42 
 3 
We also show that encapsulation successfully works with a stable colloidal aqueous dispersion 43 
of iron clusters stabilized in ferritin cages. This compartmentalization approach combining self-44 
assembly with an orthogonal nonequilibrium dispersion of nanoparticles shows untapped 45 
potential for synthesizing unusual classes of mixed matter. 46 
 47 
Introduction 48 
  Encapsulation of nanoparticles into topologically-closed liposomes represents one of 49 
the most valuable advances for therapeutics purposes, because it enables an integration of  the 50 
properties (e.g., optical, magnetic, and luminescent) of nanoparticles (NPs) with those of 51 
liposomes (protection, stability, biocompatibility).1 Since the early 80s, nanoparticle-loaded 52 
liposomes have been explored to probe cell-liposome interactions on gold2 and magnetite.3,4 53 
More recently, there has been more focus on the the diversity of not only the nature of the 54 
encapsulated NPs, like silica and quantum dots,5 but also to achieve better encapsulation 55 
methods.6 The latter allows, for instance, high NPs load uptakes by the liposomes7 or the 56 
development of stimuli-responsive vectors based on lipids8,9 or polymers.10,11,12 In the last 57 
decade, liposomal encapsulation of iron-loaded ferritin cages has even been associated with the 58 
fundamental questions underlying the origins of life.13 59 
  The case of magnetoliposomes, an idea being at least three decades old,3,4,14 is 60 
particularly interesting. Magnetoliposomes refer to liposomes that contain magnetic NPs 61 
(mainly Fe3O4 and g-Fe2O3) in their lumen, lipid bilayer or at the vesicle surface,1,9,15 and which 62 
are particularly interesting for the well-known applications in hyperthermia or as contrast agent 63 
in magnetic resonance imaging.16 Either alone or in combination with drug loading, liposomal 64 
protection increases the blood circulating time, bioavailability and delivery.1,8,9 The first 65 
reported preparation approach to insert NPs into the liposome lumen employed a classical 66 
precipitation method:4 simple mixing of pre-formed DMPG17 and DPPG18 phospholipid 67 
liposomes with lauric acid coated Fe3O4 particles was shown to precipate NP-loaded vesicles.  68 
Other methods have been employed, such as reverse phase evaporation,14,19,20,21 or in-situ 69 
liposomal precipitation of the NPs.6 Thin film hydration, double emulsion methods, or ethanolic 70 
injection can also be used.13,21,22,23 Recent review papers address the synthesis of 71 
magnetoliposomes more extensively.1,9,16 Similar encapsulation strategies are employed for 72 
other materials such as metal,24 oxides5 or luminescent nanoparticles including quantum dots5 73 
and upconverting lantanide-doped fluorides.25 74 
  Although these methods are valuable, some of them use toxic halogenated solvents (e.g., 75 
chloroform), require elaborate methodologies (e.g., evaporation under vacuum) and in general 76 
 4 
the use of stable colloids. The latter is an important point. Most, if not all, of these methods 77 
require the use of stable colloids in general. In most cases, many nanoparticle systems are 78 
passivated by a hydrophobic layer,25 which easily guarantees encapsulation in the vesicle 79 
bilayers.9,15,16 However, ligand exchange, commonly regarded at as tedious unavoidable step, 80 
use of surfactants or hydrophilic coatings, become then necessary for encapsulation in the 81 
lumen in water-based media.16,21 Moreover, the interaction between the (coated or uncoated) 82 
NPs with the phosphate groups of phospholipids may destabilize the bilayer membrane, thereby 83 
affecting the vesicle formation mechanism and reducing their stability.1,9 It is then interesting 84 
to develop an encapsulation water-based method applicable to a broad range of colloids out of 85 
thermal equilibrium. Non-equilibrium encapsulation is generally obtained in food and material 86 
science through dynamic processes such as spray drying,26,27 while recent theoretical work 87 
could explore its possibilities in the compartimentalization within elastic geometries like 88 
carboxysomes.28 89 
  Lipid switches29,30 were recently combined with classical phospholipid liposomes to 90 
deliver a cargo upon application of an external stimulus (pH, ion). In this paper, we take 91 
inspiration of this concept to develop a fully water-based (at nearly neutral pH) bulk phase-92 
change method to encapsulate, rather than release, a cargo composed of metastable colloids into 93 
vesicles. The latter are compartments entirely free of phspholipids and only composed of pH-94 
responsive lipid switches. Vesicle formation is dynamic, reversible, rapid and entirely 95 
controlled through pH. We apply this method to the formation of magnetoliposomes, chosen as 96 
model system abundantely described in the literature,4,9 from an unstable dispersion of bare 97 
(uncoated) maghemite g-Fe2O3 nanoparticle aggregates. We then extend it to the encapsulation 98 
of hydrophobic, oleic acid coated, NaYF4:Yb/Ln (Ln= Er or Tm) upconverting nanocrystals.
31 99 
Both systems, otherwise sedimenting/segregating in/from water, are driven out of equilibrium 100 
by applying strong sonication before encapsulation through a pH-jump process. 101 
  The method proposed here involves a lamellar-to-vesicle phase transition, conceptually 102 
analogous to the mechanism occurring in thin film hydration or in the preparation of 103 
vesosomes,32 but driven by a simple pH jump (generally ~4 to ~6) in bulk water. Instead of 104 
common complex formulations combining phospholipids with pH-responsive lipids8,33,34 or 105 
block-copolymers,35 we use a single pH-sensitive microbial glycolipid (GL) (Figure 1).36 106 
Microbial glycolipids are biobased compounds known for their stimuli-responsive 107 
properties,37,38,39 their biodegradability and low toxicity,40-45 and for these reasons particularly 108 
interesting for biomedical applications. GL are known to form a set of closed vesicular 109 
microphase via a simple pH-jump below ≤6.2 and a lamellar precipitate below pH ~4.46  110 
 5 
  Using a combination of cryo-TEM, light and X-ray scattering, we find that high loads 111 
of nanoparticles tend to occupy a limited number of vesicular compartments. This feature is 112 
also observed upon loading of ferritin nanocages,47 a result which agrees with the finding of 113 
Luisi et al.,13 who proposed that the massive occupation of a small fraction of vesicles, 114 
coexisting with a large majority of empty vesicles, could explain the compartimentalization of 115 
heregenous genomic material in the early stages of life formation.  116 
 117 
Figure 1 - Acidic form of the microbial glucolipid GC18:1 (GL) and its corresponding pH-dependent phase 118 
behaviour at room temperature: micelles, vesicle, lamellar. 119 
 120 
Material and Methods 121 
Synthesis of glycolipid GC18:1 (GL). GLs were produced in a scaled-up bioreactor 122 
experiment (100 L) by the S. bombicola strain ∆ugtB1 described by Saerens et al.36 The detailed 123 
production, purification and hydrolysis process to obtain the compound in Figure 1 has been 124 
reported elsewhere.46 GLs contain about 90 % and 7 % of the subterminal (glycosidic bond 125 
between glucose and the C17 of the fatty acid chain, Figure 1) and terminal (glycosidic bond 126 
between glucose and the C18 of the fatty acid chain) congener, respectively. The remaining 3 127 
% is constituted by di-unsaturated C18:2 and saturated C18:0 impurities. 128 
Preparation of iron oxide nanoparticles (NPs). Iron oxide NPs were synthesized 129 
using the co-precipitation method by adapting the standard protocol48,49 to obtain the inverse 130 
spinel structure typically observed in magnetite, where [Fe2+]/[Fe3+]= 0.5. Specifically, 0.177 g 131 
of FeCl3 •
 6H2O was mixed with 0.108 g of FeCl2 •
 4H2O in a round-bottom flask containing 20 132 
mL of Milli-Q water. To this solution, 2.7 mL of a 28 % ammonium hydroxide solution was 133 
gradually added under continuous mechanical stirring. The system was maintained in an argon-134 
rich environment to limit oxidation. The resulting black precipitate was extracted by 135 
magnetically-assisted sedimentation and washed with MilliQ water. This operation was 136 
repeated three times to remove any residual salts. 137 
Preparation of upconverting nanoparticles (UCNP). Upconverting oleic acid capped 138 
NaYF4:Yb/Er and  NaYF4:Yb/Tm nanoparticles (20%-Yb and 0.5%-Ln, Ln= Er, Tm) molar 139 
pH 9 pH 4pH 6
 6 
ratio replacing yttrium ions in the lattice, labelled as UCNPs) of size between 20 nm and 40 nm 140 
were prepared according to ref. 50.   141 
Iron-loaded ferritin cages preparations and characterization. The iron-loaded 142 
ferritin cages (AfFtn) are prepared as previously described.47,51 Briefly, the ferritin is derived 143 
from the archaeon Archaeoglobus fulgidus and was produced recombinantly in E. coli strain 144 
BL21(DE3)CodonPlus-RIL (Stratagene) with IPTG induction. The harvested cells were 145 
sonicated and heat-treated at 85°C for 10 minutes. The insoluble fraction and denatured proteins 146 
were removed using ultracentrifugation and the supernatant was passed through 0.22 µm filter. 147 
No further purification was performed for this report. Iron was loaded by adding Fe2SO4 148 
dropwise until 4800 Fe/cage had been loaded. To remove the unloaded iron, the sample was 149 
desalted, concentrated using 100 kDA MWCO Amicon filter, and sterile filtered using 0.22 µm 150 
syringe filter. The iron-loaded ferritin (Fe4800)AfFtn preparation was characterized by 151 
dynamic light scattering (DLS) technique to confirm that the hydrodynamic size was ~13 nm 152 
and the protein concentration was estimated using Bradford assay.47,51 153 
NPs-containing vesicle preparation. Ten mL of the NPs solution were set to pH 9 and 154 
bath-sonicated during 30 min to one hour. After sonication, the NPs solution was mixed at room 155 
temperature to 10 mL of a micellar GL solution (0.29 g GL in 10 mL) at pH 9. The NPs GL 156 
mixture at pH 9 (referred to NPs GL, pH9, sample S2) was kept under stirring for few minutes 157 
before use. Note: the NPs solution is not sonicated in the presence of the GL solution. According 158 
to the data in Baccile et al.,46 GL self-assembles into vesicles at pH values below 6.2. Thus, to 159 
prepare vesicles, two aliquots of the NPs GL solution at pH 9 were acidified using 1 M HCl 160 
solution: in aliquot 1, the pH is lowered to 6, and this sample is referred to as NPs GL, pH6 161 
(sample S3) and in aliquot 2, the pH is lowered below 4 and then increased again to pH 6 and 162 
named NPs GL, pH2→pH6 (sample S4). The latter will also be referred to as the manual pH-163 
jump approach 2, where approach 1 corresponds to sample S1, that is a control experiment 164 
only containing NPs and free of GL. In a second control experiment (sample S5), the pH of the 165 
NPs (GL-free) solution was lowered to 6 with 1 M NaOH, and 0.45 g of non-acetylated acidic 166 
sophorolipids were subsequently added, similarly to the two-step procedure described in 167 
Baccile et al.55 Sophorolipids are microbial glycolipids having a disaccharide headgroup and 168 
known to self-assemble into micelles, instead of vesicles, under the acidic pH conditions.46 The 169 
detailed sample compositions are given in Table 1.  170 
Table 1 – Composition table of the samples studied in this work. GL: acidic glucolipid GC18:1 (Figure 1), 171 
NPs: g-Fe2O3 nanoparicles,55 SL: sophorolipids.55 The concentration of NPs mother solution is estimated by 172 
gravimetric analysis. Samples S2 through S5 are obtained by mixing 1:3 vol:vol of mother GL (40 mg/mL) 173 
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and NPs (4.2 mg/mL) solutions, both at pH 9. pHi, pHm and pHf respectively indicate the initial, middle and 174 
final pH. If no pH change has occurred, pHi = pHf. All pH variations are performed by hand using 1 M HCl 175 
and 1 M NaOH solutions. 176 
Sample name 
Sample 
code 
CGL / 
mg/mL 
CSL / 
mg/mL 
CNPs / 
mg/mL 
pHi pHm pHf 
GL - 10 - - 9 - 6 
NPs S1 - - 4.2 9 - 9 
NPs GL pH 9 S2 10 - 3.2 9 - 9 
NPs GL pH 6 S3 10 - 3.2 9 - 6 
NPs GL pH 2 → pH 
6 
S4 10 - 3.2 9 2 6 
NPs SL pH 6 S5 - 10 3.2 9 - 6 
 177 
The manual pH-jump (approach 2) described above has been performed manually and 178 
for this reason we have tested a series of additional methods to evaluate the robustness of the 179 
encapsulation process and to control the vesicle size distribution. These experiments have been 180 
performed on both a NPs-free solution constituted of vesicles only (GL in Table 1) and a mixed 181 
NP and GL (sample S4 in Table 1). Extrusion (approach 3): after the manual pH-jump 182 
(approach 2) the solution is extruded (10 cycles) at 1 mL/min through a 0.45 μm filter. 183 
Extrusion is commonly used to control vesicle size in the hundred nanometer range.52,53,54 184 
Sonication (approach 4): after the manual pH-jump (approach 2), the solution is sonicated for 185 
20 s using an immersive ultrasound probe. Sonication is commonly used to prepare vesicle of 186 
diameter below 100 nm.52 Controlled pH-jump (approach 5): after the pH is lowered to 2, pH 187 
is increased to 6 using a 1 M NaOH solution injected at 0.5 μL/min under stirring. Dialysis pH-188 
jump (approach 6): after the pH is lowered to 2, pH is increased to 6 by dialyzing the solution 189 
against a water reservoir at pH 6 using a 3500 MWCO (Spectra/Por®) membrane. Finally, to 190 
guarantee homogeneous dispersion of the vesicles and NPs, solution are kept under stirring 191 
during the manual pH-jump and controlled pH-jump processes. 192 
Preparation of iron-loaded ferritin-containing vesicles. The procedure was adapted 193 
from the NPs-containing vesicle process. The stock (Fe4800)AfFtn solution (0.88 mg/mL, pH 194 
7.4) was mixed with the a micellar GL solution (40 mg/mL, pH 7.4) to achieve respective final 195 
concentrations of 0.66 mg/mL and 10 mg/mL. The pH was then lowered to about 3.9 (using ~ 196 
6 μL HCl 5 M) to avoid (Fe4800)AfFtn aggregation. The pH is then increased to 6 using three 197 
selected approaches described above. Manual pH jump (approach 2): pH is manually increased 198 
by manual addition of 1 M NaOH solution. Controlled pH-jump (approach 5): a 1 M NaOH 199 
solution is injected at 0.5 μL/min under stirring until pH 6 was achieved. Extrusion (approach 200 
3): the (manual) pH jump solution is extruded (10 cycles) at 1 mL/min through a 0.45 μm filter. 201 
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Note: (Fe4800)AfFtn is water-dispersible, therefore it is never sonicated.  202 
Preparation of UCNP-containing vesicles. To a 10 mg/mL micellar GL solution in 203 
water at pH 9, we add the dried oleic-acid-capped NaYF4:Yb/Er and NaYF4:Yb/Tm UCNP 204 
powder at concentration of 5 mg/mL. The UCNP sample is water-insoluble and for this reason 205 
sonication is necessary to help dispersion. For the encapsulation, we employ the manual pH 206 
jump (approach 2): pH is reduced to 4 (manual dropwise addition of μL amounts of 0.5 M HCl) 207 
and then increased to ~6 (manual dropwise addition of μL amounts of 1 M NaOH). The same 208 
protocol applies to a control solution only containing the UCNP sample, without adding GL. 209 
Despite the hydrophobic character of the oleic acid-coated UCNP, sonication is enough to 210 
disperse them in water, although sedimentation is fast for the control, GL-free, experiment. 211 
Sedimentation experiments using photoluminescence spectroscopy. Free 212 
sedimentation: the UCNP dispersion is placed in a quartz cuvette and irradiated with a CW laser 213 
source (λ= 980 nm) at a power density of 105 W/cm2. Emission spectra were recorded after 0, 214 
10, 20, 30, 60, 120, 300, 600, 1200, 1800, 3600, 5400 s. Forced sedimentation: The setup and 215 
conditions for photoluminescence measurements were identical to the free sedimentation. 216 
However, the encapsulated UCNP dispersion was centrifuged at 2000 rpm in a time scale 217 
comprised between 0 and 300 seconds, and emission spectra were taken after 10, 20, 30, 60, 218 
120 and 300 seconds of centrifugation. 219 
Light scattering (LS) experiments. Light scattering experiments were performed on a 220 
Malvern Zetasizer Nano ZS instrument (λ= 633 nm) at constant shutter opening and same 221 
sample-to-detector distance. The diffused light was expressed in terms of the derived count rate 222 
in kilocounts-per-seconds (kcps). All solutions were diluted 100 times prior to analysis. Two 223 
measurements were performed, the first one on the solution itself and the second one on the 224 
supernatant of the same solution, after magnetically-assisted sedimentation of the suspended 225 
NPs using a neodymium magnet. 226 
Transmission Electron Microscopy (TEM). TEM was performed on a FEI Tecnai 120 227 
Twin microscope operating at 120 kV and equipped with a high resolution Gatan Orius CCD 228 
4k x 4k numeric camera. DigitalMicrograph™ software was used for image acquisition. TEM 229 
images acquired in cryogenic mode were obtained from the same instrument. The sample holder 230 
was a Gatan Cryoholder (Gatan 626DH, Gatan). DigitalMicrograph™ software was used for 231 
image acquisition. Cryo-fixation was done on a homemade device. The solutions were 232 
deposited on glow discharged holey carbon coated TEM copper grids (Quantifoil R2/2, 233 
Germany). Excess solution was removed and the grid was immediately plunged into liquid 234 
ethane at -180°C. All grids were kept at liquid nitrogen temperature throughout all 235 
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experimentation. 236 
Small Angle X-ray Scattering (SAXS). SAXS experiments were recorded at the high 237 
brilliance ID02 beamline at the ESRF synchrotron (Grenoble, France) using a 1 m detector-to-238 
sample distance and a flow-through polycarbonate capillary. Aquisition time was  239 
1 s per pH value. pH was changed in-situ in the experimental hutch and followed live. More 240 
details on the experimental setup have been provided in Baccile et al.46 Data were acquired 241 
using a CCD camera and integrated azimuthally to obtain a typical I(q) spectrum. Contribution 242 
of the solvent (water at pH 11.6) and capillary were measured prior to the experiment and 243 
accordingly substracted during the data treatment. All data were corrected for the transmission 244 
of the direct beam. 245 
Additional SAXS experiments were performed on a laboratory three-pinhole type S-246 
MAX 3000 RIGAKU Nanoviewer instrument using a monochromatic Cu-Kα radiation 247 
produced by a microfocus (20 microns x 20 microns) sealed tube X-ray source (MicroMax 002+ 248 
RIGAKU working at 40 W) and equipped with a two-dimensional multi-wire proportional gas 249 
detector. The sample-to-detector distance was set to 1469 mm. The applied voltage and filament 250 
current were 40 kV and 50 mA respectively. The q-range calibration was made using a silver 251 
behenate standard sample (dref = 58.38 Å). The measured intensity was always divided by the 252 
sample transmission and appropriate masking was done to eliminate the beam-stop shadow 253 
contribution and imperfection of the 2D detector. Quartz sample holders of 1 mm diameter were 254 
used in a flow-through mode using a home-made device, thus assuring that the background 255 
signal was constant for all samples. The subtracted background was constituted by the water-256 
containing quartz capillary. The acquisition time per sample is 1 h. 257 
X-ray Didffraction (XRD). XRD data were recorded on the dried powders using a 258 
Bragg-Brentano θ-2θ (λ= 1.54 Å) goniometer Bruker D8 Discover instrument. 259 
Differential thermal analysis (DTA). DTA was performed in a Mettler-Toledo 260 
TGA/SDTA851e/LF/1600 instrument. The analysis of the powders was carried out in Pt 261 
crucibles at a heating rate of 5 ºC/min under air atmosphere over the range of 20-900 ºC and 262 
using alumina as reference. 263 
Photoluminescence spectroscopy. Upconversion photoluminescence was recorded 264 
using an infrared laser diode RLTMDL-980-2W module (980 nm ± 5 nm, 2 W cw) from 265 
Roithner LaserTechnik, and a Black Comet CXR (StellarNet) optical fiber as detector. The 266 
emission was measured using dispersions of the UCNPs (10 mg in 1mL of ethanol for bare 267 
nanoparticles, or in 1 mL of water for the samples encapsulated in glycolipids) and focusing 268 
the laser on the samples at a pump density of 105 W/cm2. 269 
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 270 
Results and discussion  271 
Encapsulation of sonicated iron oxide nanoparticles. The XRD of the bare iron oxide 272 
NPs is represented by the diffractogram N°1 on Figure 2, which shows the d-values: 2.967, 273 
2.527, 2.092, 1.714, 1.614, 1.478 Å, corresponding, to the (220), (311), (400), (422), (511), 274 
(440) Bragg diffraction planes of the iron oxide spinel cubic structure (JCPDS file, N° 19-275 
0629), respectively. This is attributed to a maghemite structure, previously identified using 276 
Mössbauer spectroscopy.55 The typical size (below 10 nm) and aggregation state of this sample 277 
are shown by TEM in Figure S 1 (sample referred to as NPs).55 The magnetic nature of the NPs 278 
(Figure 3) shows the attraction of the NP sample to the magnetic field of a neodymium magnet 279 
leaving the supernatant solution completely clear. The observation is also confirmed by the 280 
light scattering (LS) data in Figure 3 (sample S1) before (white bars, strong scattering) and after 281 
(grey bars, no scattering) exposure to the magnet. This is explained by the strong aggregation 282 
of the uncoated NPs (Figure S 1, NPs sample) in water. On the other hand, GL mainly assembles 283 
into micelles in water at pH 9, as shown by the characteristic SAXS scattering signal, shown in 284 
Figure 2b. The same compound is also known to form vesicles when the pH is lowered from 9 285 
to 6, as previously demonstrated by us37,46 and shown here by the typical SAXS scattering signal 286 
recorded at pH 6.07 in Figure 2b. The SAXS pattern is characterized by a broad oscillation at 287 
q above 0.1 Å-1, attributed to the form factor of a lipid bilayer, and an intense scattered intensity 288 
at q below 0.05 Å-1, the slope of which in log-log scale is close to -2, a typical value found for 289 
planar surfaces. A detailed analysis of the form factor through model-dependent fitting of SAXS 290 
data presented in Figure 2b can be found in ref. 37. 291 
Addition of GLs to the bare nanoparticle solution at pH 9 does not modify the NPs 292 
crystal structure (XRD pattern N°2, Figure 2a), nor the overall aggregation state (sample NPs 293 
GL, pH9 in Figure S 1). However, upon exposure to the magnet most NPs are removed from 294 
the solution, but the latter still has a light brown colour, indicating a small dispersion of NPs in 295 
solution. This is confirmed by the slightly higher scattering signal in LS data (sample S2) in 296 
Figure 3. Given the strong molecular similarity between GLs and sophorolipids (SLs), GLs can 297 
certainly stabilize a small fraction of the iron oxide NPs by a simple adsorption at their surface 298 
via the carboxylate group, a phenomenon observed in a previous study.55 299 
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 300 
Figure 2 – a) X-ray diffraction patterns of 1) iron oxide NPs, 2) NPs GL at pH 9 and 3) NPs GL at pH 6. 301 
Reported values relate to the Miller (hkl) indices of the Bragg diffraction planes. b) SAXS curves were 302 
recorded on the ID02 line of ESRF synchrotron for a pure GL solution at pH values between 3 and 9. The 303 
solutions at pH 6.07 and pH 3.19 have been directly obtained from the solution at pH 9.00 by adding 1 M 304 
HCl solution.  305 
 306 
 When the pH of the NPs GL solution is lowered from 9 to 6, one can confirm that the 307 
nanoparticle crystal structure is intact (XRD pattern N° 3, Figure 2a). Upon approaching an 308 
external magnet to the vial, most NPs are attracted, thus leaving the solution slightly yellowish 309 
(Figure 3b, sample S3) due to the spurious presence of GL-coated NPs in solution. Light 310 
scattering of sample S3 (diluted, Figure 3a) qualitatively confirms the loss in the scattered 311 
intensity of the supernatant upon magnetically-assisted sedimentation. Nevertheless, Figure 3b 312 
shows that sample S3 (undiluted) supernatant is slightly turbid, if compared to samples S1 or 313 
S2; this is explained, and actually expected,46 by the presence of vesicles, confirmed by SAXS 314 
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(Figure 2b) and the image in Figure 3b (GL, pH 6), both corresponding to a NP-free GL solution 315 
at pH 6. The TEM image of sample 3 (NPs GL pH6, Figure S 2a) confirms that nanoparticle 316 
size, morphology, structure and aggregation are not affected by the presence of the GL. 317 
However, GL can stabilize the nanoparticle surface, as commented above and as expected from 318 
the previous work performed on sophorolipids-stabilized iron oxide nanoparticles.55 Light 319 
scattering experiments performed on sample S3 (Figure 3b), as well as its dim yellowish colour 320 
and aggregation state (Figure S 2a) are comparable to a control system composed of 321 
sophorolipid-stabilized iron oxide nanoparticles (sample S5, Figure 3a, Figure S 1, Figure 3b). 322 
 323 
Figure 3 – Light scattering data (a) and magnetically-assisted sedimentation images (b) for bare NPs 324 
(sample S1), GL-containing NPs at pH 9 (NPs GL, pH9, sample S2), GL-containing NPs at pH 6 (NPs GL, 325 
pH6, sample S3), GL-containing NPs at pH 6 after a transition at pH 2 (NPs GL, pH 2 → pH 6, sample S4), 326 
NPs-free GL solution at pH 6 (GL, pH6) and SLs-containing nanoparticle solution at pH 6 (NPs SL pH6, 327 
sample S5. Sample S5: control sample composed of sophorolipids-stabilized iron oxide NPs.55 328 
 329 
GLs are known to precipitate into a lamellar phase when the pH is lowered below 4,46 330 
also illustrated by the SAXS pattern recorded on a nanoparticle-free GL solution at pH 3.19 and 331 
shown in Figure 2b. In the last figure, two sharp diffraction peaks at q = 0.18 Å-1 and 0.36 Å-1 332 
overlaps the typical vesicle form factor profile; they respectively correspond to the first and 333 
second order interplanar distances lamellar stacking (d= 34.8 Å and d= 17.4 Å). The cryo-TEM 334 
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analysis of a GL nanoparticle solution at pH below 4 displays the coexistence of nanoparticle 335 
clusters and flat lamellae (Figure S 3). Under these conditions, NPs can be easily removed by 336 
magnetically-assisted sedimentation, leaving a solid white precipitate in the vial. However, 337 
when pH is increased again to 6, the nanoparticle solution becomes extremely stable towards 338 
magnetically-assisted sedimentation: light scattering of sample S4 (Figure 3) indicates strong 339 
scattering before and after sedimentation. This is confirmed by the images showing the 340 
magnetically-sedimented undiluted sample (Figure 3b, sample S4): the dark solution indicates 341 
that most NPs are now stabilized. We anticipate that stability is observed over several hours of 342 
continuous exposure to the neodymium magnet. 343 
Figure S 2b-d show that particle size (~10 nm) is unchanged compared to the GL-free 344 
NP solution and high magnification (Figure S 2b) and Fourier transform (Figure S 2c) indicate 345 
the crystallinity (Figure S 2d) of the particle with a typical distance of 2.9 Å, attributed to the 346 
(220) plane of maghemite. 347 
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 348 
Figure 4 – a-d) Cryo-TEM images of NPs GL samples obtained after a pH jump (pH 9 →) pH 2 → pH 6 349 
(NPs GL pH2→pH6, sample S4). e-g) Laboratory SAXS data recorded on e) bare NPs and NPs-free GLs at 350 
pH 6 (GL pH6), f) NPs GL samples at pH 6 directly adjusted from pH 9 (NPs GL pH6, sample S3) before 351 
(black curve) and after (grey curve) magnetically-assisted sedimentation, g) NPs GL samples at pH 6 352 
adjusted from pH 9 after passing through pH 2 (NPs GL pH2→pH6, sample S4) before (black curve) and 353 
after (grey curve) magnetically-assisted sedimentation 354 
 355 
Although GL adsorption is not excluded, the only surface passivating effect of GL 356 
cannot explain the colloidal stability at pH 6, because only a fraction of the NPs are in fact 357 
concerned, as already shown for sample S3 and control sample S5.55 The remarkable stability 358 
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of the nanoparticle suspension is rather explained by the encapsulation of nanoparticle clusters 359 
within (mainly) multilamellar vesicles, as shown by cryo TEM experiments in Figure 4a-d. 360 
These data are statistically-confirmed by complementary SAXS experiments presented in 361 
Figure 4e-f: panel a) shows the typical signatures of bare NPs (black curve) and GL in solution 362 
at pH 6 (grey curve). The difference in the scattering intensity (although not in absolute scale) 363 
reveals the strong difference between NPs and GL in terms of contrast with the solvent (water). 364 
Additionally, the high-q region above 0.1 Å-1 in the GL sample, although very noisy, shows the 365 
beginning of the form factor oscillation, which is very clear in the synchrotron-collected data 366 
on a larger q-scale (Figure 2b, pH 6.07). The highly stable pH 2 → pH 6 system (Sample S4, 367 
Figure 4g) shows that the signal is dominated by the NPs scattering before and after 368 
magnetically-assisted sedimentation, thus confirming that vesicles prevent their removal.  369 
Finally, we have specifically verified the orthogonality between vesicle-formation and 370 
NPs dispersion:  the pH 9 → pH 2 → pH 6 method is applied to a NPs-free GL solution and the 371 
corresponding cryo-TEM images in Figure S 4 confirm the presence of vesicles, and in 372 
particular of multilamellar vesicles. One can compare these results to the sample S3 (NPs GL 373 
pH 9 → pH 6), of which the cryo-TEM (Figure 5) and SAXS (Figure 4f) before (black curve) 374 
and after (grey curve) magnetically-assisted sedimentation indicate that the NPs are not 375 
preferentially encapsulated. Cryo-TEM shows that the NPs mostly aggregate around vesicles, 376 
while SAXS shows the typical signal of the NPs before and a pattern typical of the vesicles 377 
after magnetically-assisted  sedimentation.  378 
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 379 
Figure 5 – Cryo-TEM images of NPs GL samples prepared at pH 6 directly adjusted from pH 9 (NPs GL 380 
pH 6, sample S3) 381 
 382 
Stability, control of the size distribution and quantification. Time-dependent stability and 383 
size control of the encapsulated NPs are two important parameters for potential applications in 384 
nanomedicine and they are tested hereafter. Figure 6 shows the time stability of a GL solution 385 
mixed with NPs in the presence and absence of a magnet employing different approaches of 386 
encapsulation, but all performed using the pH jump (pH 9 → pH 2 → pH 6) process (sample 387 
4). Approach 1 and approach 2 are, respectively, the vesicle-free NPs (sample S1) control and 388 
the manually-controlled pH jump (sample S4). Among the others, approach 3 and approach 4 389 
respectively use extrusion and sonication after encapsulation, both being classical methods to 390 
control vesicle size in the 100 nm range (extrusion)52,53,54 and below 50 nm (sonication).52 391 
Extrusion is also commonly employed to obtain unilamellar vesicles from multilamellar 392 
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vesicles. Finally, approach 5 and approach 6 are meant to perform the pH 2 → pH 6 jump 393 
either through a controlled NaOH injection (1 M NaOH at 0.5 μL/min, approach 5) or through 394 
a very slow modification in pH (approach 6, using dialysis). Without vesicles (filled squares, 395 
Figure 6), the NPs sediment after several minutes in the absence of magnet, as expected from 396 
the Stokes law, while sedimentation is immediate upon use of a magnet. Whichever the 397 
approach of encapsulation, all vesicles-stabilized NPs solutions are similarly stable in time 398 
against sedimentation (Figure 6, left-hand): after 15 h, the transmittance is almost constant, 399 
while the vesicle-free control is clear. In the presence of a magnet (Figure 6, right-hand), none 400 
of the solution shows the same immediate collapse as found in the vesicle-free control (black 401 
squares), thus indicating that encapsulation is always successful. However, after 2 h of exposure 402 
to the magnet, the transmission is not equivalent among the tested solutions, probably indicating 403 
a disparity in terms of the encapsulation efficiency. Extruded, sonicated and controlled pH jump 404 
(respectively, approach 3, 4 and 5) seem to be the most efficient approaches. 405 
  406 
 407 
Figure 6 – Time-dependent stability of NPs GL pH 2 → pH 6 (sample S4) using approaches 1 through 6 408 
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(refer to figure and materials and methods section). Data on the left-hand side refer to simple decantation 409 
(no magnet) while data on the right-hand side are acquire using magnetically-assisted sedimentation of the 410 
solution (vials sit on a neodymium, as shown on figure) 411 
 412 
Extrusion is known to be a severe process that can destabilize the most stable 413 
nanoparticle systems.56 Vesicles-stabilized NPs prepared by pH jump provide an ultra-stable 414 
dispersion of NPs upon extrusion (approach 3). Video 1 shows that a vesicles-stabilized NP 415 
solution can be extruded repeatedly (we tested up to ten cycles) without aggregation of the NP 416 
onto the filter, while a vesicle-free NP solution cannot be extruded once (Video 2). The 417 
advantage of employing various sample preparation approaches is the possibility to control the 418 
vesicles size distribution, as formulated theoretically in the development of nonequilibrium 419 
compartments.28 Figure 7 shows the autocorrelation function and the corresponding number 420 
distribution of the (vesicle-free) iron oxide NPs solution (in red), the (NPs-free) GL vesicle 421 
solution obtained through the pH jump (in green) and the vesicles-stabilized NPs solution (in 422 
black) obtained with approaches 2 through 6. Both manual and dialysis pH jump approaches 423 
provide a heterogenous dispersion of vesicles and NPs with a broad size distribution, in 424 
agreement with the cryo-TEM images of sample 4 in Figure 4. On the contrary, extrusion, 425 
sonication and controlled pH jump provide a homogeneous set of NPs dispersion, of which the 426 
size distribution can be tuned between 50 nm (sonication) and 500 nm (controlled pH jump). In 427 
particular, the comparison between the autocorrelation function of the NPs-free vesicles and 428 
the vesicles-stabilized NPs systems in the controlled pH jump approach clearly shows that the 429 
size distribution of the latter is controlled by the process of vesicle formation. Selected cryo-430 
TEM images for the sonication  and extrusion processes are also shown in Figure 7 (right-hand 431 
side) to support the DLS data. Cryo-TEM shows that sonication produces vesicles between 20 432 
nm and 50 nm, while extrusion produces vesicles of size contained between about 100 nm and 433 
300 nm. In both cases the average size and size distribution are in good agreement with the DLs 434 
data. White arrow in the cryo-TEM image recorded on the extruded vesicles-stabilized NPs 435 
system also shows a typical vesicle highly loaded with iron oxide NPs. 436 
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 437 
Figure 7 – Autocorrelation functions (left-hand panels) and number size distribution (right-hand panels) of 438 
NPs GL pH 2 → pH 6 solutions (sample 4) prepared using approaches 2 through 5, respectively referring 439 
to (manual) pH jump, extrusion, sonication, controlled pH jump and dialysis pH jump. The experimental 440 
detail of each approach is provided in the materials and methods section. To support the DLS data on size 441 
control, cryo-TEM images are provided on the right-hand side for the sonication and extrusion methods. 442 
White arrow point at a typical vesicle highly loaded with iron oxide NPs. 443 
 444 
Vesicles-stabilized NPs can be reproducibly prepared by the pH jump approach, which 445 
controls a lamellar-to-vesicle phase transition when passing from highly acidic pH (it works 446 
between 2 and 4) to pH ~6. Stability and size control of the NP-encapsulated vesicles depends 447 
on the method the lamellar-to-vesicle phase transition line is crossed. This behaviour identifies 448 
a kinetically controlled process, where the non-equilibrium NPs dispersion is randomly 449 
encapsulated during the process of bilayer folding into vesicles. To estimate the repeatability 450 
of the encapsulation process and the loading efficiency, the manual pH jump experiment 451 
(sample S4 in Figure 3, approach 2 in Figure 6) was repeated twenty times. By a simple 452 
gravimetric method, we find an encapsulation efficiency of 59.2 ± 16.0 %. These values are 453 
obtained by weighting the mass of the NPs collected through the magnetically-assisted 454 
sedimentation with respect to the total mass of the initial NPs load. Figure S 5 qualitatively 455 
shows two systems, where the NPs retain rate in solution is in the order of 50 % (Figure S 5b) 456 
and above 50 % (Figure S 5c), and where Figure S 5a shows the control image of a typical NPs-457 
free GL vesicle solution. Considering the broad variation across experiments in the 458 
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encapsulation efficiency (± 16.0 %), we did not estimate useful to perform more precise 459 
measurements. However, loading efficiency values above 50 % can be compared with the 460 
highest values reported in the literature for magnetoliposome systems, with encapsulation 461 
occurring both in the lumen and bilayer.57,58,59,60 462 
 463 
Understanding the uneven encapsulation profile. At the moment, the only hypothesis 464 
supporting the encapsulation of magnetic iron oxide NPs (magnetoliposomes) is the lamellar-465 
to-vesicle transition occurring during the pH 2 → pH 6 jump process, a similar process 466 
described for vesosomes from cochleate cylinders,32 or in more standard thin film hydration.13 467 
In this work, such a mechanism is strongly suggested by the fact that both unilamellar and 468 
multilamellar vesicles are produced during the micelles-to-vesicle (pH 9 → pH 6)46 and 469 
lamellar-to-vesicle (pH 9 → pH 2 → pH 6, Figure S 4) transition. The folding process of the 470 
bilayer membrane into closed objects during the pH 2 → pH 6 jump, and which was already 471 
shown to be driven by temperature for GL,46 internalizes the NPs in solution. Nanoparticles are 472 
locally aggregated but their volumetric distribution is homogeneous at a macroscopic scale due 473 
to previous sonication (in the absence of GL vesicles) and stirring (in the presence of GL 474 
vesicles). Nonetheless, the variability in loading efficiency is quite high (± 16 %), a fact which 475 
can be explained by several factors. Figure 6 and Figure 7 show the impact of the encapsulation 476 
process on the stability and size distribution, where the finest control provides the most stable 477 
systems. Manual variation, although quite robust and easy to perform, obviously suffers from 478 
an intrinsic variability, especially in a kinetically controlled process. Locally, cryo-TEM shows 479 
a coexistence of heavily-loaded vesicles and empty vesicles, rather than a homogeneous 480 
encapsulation event. Interestingly, a similar behaviour was reported by Bothun59 and by Luisi,13 481 
respectively on water-dispersible magnetite and iron-loaded ferritin, the latter using a statistical 482 
approach employing cryo-TEM. Unfortunately, any attempt to improve the homogeneity of the 483 
encapsulation among the vesicles, for instance using different molarities (e.g., 1 M and 0.1 M) 484 
of NaOH, was vain, suggesting other mechanisms behind the encapsulation phenomenon. 485 
To better understand whether or not the uneven encapsulation profile is specific to this 486 
system, we have decided to repeat the pH-driven encapsulation experiment using ferritin 487 
nanocages containing an iron core. Luisi et al.13 have demonstrated that encapsulation of ferritin 488 
(performed through thin film hydration and ethanol injection) in the lumen of 1-palmitoyl-2-489 
oleoyl-sn-glycero-3-phosphatidylcholine vesicles is not described by a classical Poisson-490 
Boltzmann distribution function, but rather by a small fraction of heavily-loaded vesicles 491 
surrounded by empty ones. (Fe4800)AfFtn, characterized in ref. 51, is a water-dispersible 492 
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material similar to the one employed by Luisi et al.;13 it is characterized by an iron core (4800 493 
iron atoms) of 8 nm enclosed in a proteic cage of 13 nm in diameter.  494 
(Fe4800)AfFtn is encapsulated in GL vesicles using three main approaches: manual pH 495 
jump (approach 2), controlled pH jump (approach 5) and extrusion (approach 3). These 496 
experiments are all analyzed by cryo-TEM presented in Figure 8. Typical (Fe4800)AfFtn is 497 
indicated by the white arrows in Figure 8a1,b2. Irrespective of the encapsulation approach, we 498 
systematically observe empty, or close to empty, vesicles coexisting with loaded vesicles 499 
(Figure 8a1,b1,c1), and in few cases, highly loaded vesicles (a thorough statistical analysis is 500 
however out of the scope of this work). In particular, Figure 8b3,b4,c2,c3 show the side-to-side 501 
coexistence of extremely crowded vesicles next to empty ones, as concluded by Luisi et al.13 502 
Whether there may be an influence of the encapsulation approach or not, we do not have enough 503 
statistically-meaningful data in our possession to conclude on this point, but this is not excluded, 504 
as shown by cryo-TEM images corresponding to the extrusion approach. Figure 8c1, for 505 
instance, shows a typical example of a large burst vesicle (arrow 1), from which (Fe4800)AfFtn 506 
particles are free of diffusing from inside to outside and vice versa. One can also observe small 507 
portions of a smaller vesicle being heavily loaded (arrow 2). We did not observe similar events 508 
occurring in the manual and controlled pH jump. This can be explained by the reduction in 509 
vesicle size polydispersity (Figure 7) after extrusion, a fact that can involve vesicle bursting 510 
and intervesicular fusion.  511 
These experiments show that the phase change encapsulation approach developed in 512 
this work using the pH-responsive GL provides the same uneven distribution profile of the 513 
ferritin nanocages within the lumen of the vesicular compartments, similarly to what was 514 
described in ref. 13. To this regard, the data shown in Figure 4 are neither specific to the 515 
encapsulation of iron oxide NPs nor to the pH-driven encapsulation method, but they seem to 516 
follow an accepted, although not fully understood, distribution profile, which cannot be 517 
described by a standard Poisson-Boltzmann distribution function. On another level, the 518 
encapsulation of (Fe4800)AfFtn also suggest that the method developed in this work could be 519 
extended to the encapsulation of a broader range of water-stable nanocolloids.  520 
 521 
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 522 
Figure 8 - Cryo-TEM images of GL samples containing Ferritin-4800 (average diameter of 13 nm) obtained 523 
after a pH jump (pH 7.4 →) pH 3.9 → pH 6. The following approaches (please refer to the method section 524 
for more information) are employed: a1-a2) controlled pH jump; b1-b4) manual pH jump; c1-c3) extrusion 525 
after manual pH jump. 526 
 527 
 528 
Extending the pH-jump encapsulation to aqueous dispersions of hydrophobic oleic-529 
stabilized upconverting nanoparticles  530 
UCNP are interesting colloids with a wide variety of applications for their ability to 531 
absorb energy in the near infrared (NIR) and convert it to visible light. The most important 532 
concerns the field of bioimaging because living tissues are transparent in the NIR.31 The actual 533 
synthesis procedure occurs in organic media, from which the UCNP result in poor water 534 
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solubility due to their hydrophobic coating. Strategies to make UCNP hydrosoluble, which 535 
generally consists in tedious ligand exchange procedures, are crucial for their application in the 536 
biomedical field.  In this sense, it could be very interesting to avoid the ligand exchange step 537 
and to directly encapsulate the UCNP bearing their original hydrophobic coating. The 538 
sonication-assisted phase change method developed in the previous section for bare iron oxide 539 
NPs could be an interesting alternative to more classical encapsulation approaches,25 which 540 
would require surface engineering steps to make UCNP water-dispersible. Furthermore, as 541 
shown in many magnetoliposome systems, stable NPs bearing a hydrophobic coating 542 
classically partition in the lipid bilayer of the vesicles,1,9,15,16,56,57 and in general only the 543 
employment of surfactants, which guarantee oil-water phase transfer, forces them to aggregates 544 
in the lumen.21 Otherwise, standard hydrophilic stabilizers (e.g., citric acid, polymers) are used 545 
to surface stabilizers that help them aggregate in the lumen.16,57,59,60 In this section, we make 546 
the hypothesis that the sonication-assisted phase-change method employing the pH-responsive 547 
GL can also be used to encapsulate hydrophobic colloids under the same conditions employed 548 
to form magnetoliposomes. We employ UCNP used with an average diameter between 20 nm 549 
and 40 nm; they are composed of NaYF4:Yb/Er and NaYF4:Yb/Tm, both coated with oleic acid. 550 
Due to their oleic coating, they aggregate in water, either sedimenting or immediately adsorbing 551 
on the glass vial. 552 
NaYF4:Yb/Er and NaYF4:Yb/Tm UCNP are prepared according to a standard 553 
procedure;50 their typical XRD pattern (Figure S 6a) depicts a classical mixture of hexagonal 554 
and cubic crystal structures, while the corresponding TEM micrographs (Figure S 6b) show a 555 
polydisperse set of sub-50 nm nanoparticles (size distribution is given in Figure S 6c). The oleic 556 
hydrophobic coating is shown by DTA analysis (red profile in Figure S 6e). Given their 557 
hydrophobic coating, they are hardly water-dispersible, unless sonication is applied. In this 558 
case, the UCNP powder mix with water but it precipitates within the order of minutes, as shown 559 
by both light scattering (Figure 9a) and photoluminescence spectroscopy (Figure 9b,c). When 560 
the UCNP are added to a GL solution and are submitted to a manual pH jump (approach 2), we 561 
find a prompt dispersibility in water and an enhanced colloidal stability. Combination of light 562 
scattering (Figure 9a, sensitive to both nanoparticles and vesicles), with photoluminescence 563 
spectroscopy (Figure 9b,d, only sensitive to UCNP), show stability of the encapsulated UCNP 564 
in solution up to one hour. The stability is also confirmed by photoluminescence spectroscopy 565 
data recorded on a series of centrifuged samples: encapsulated UCNP emit significant amount 566 
of light up to 2000 rpm for as long as 1 min of centrifugation time (Figure 9e). These results 567 
are independent of the nature of doping element (Er or Tm). These data are also completed by 568 
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XRD and DTA results (Figure S 6d,e) showing that encapsulation does not affect the crystalline 569 
structure of the UCNP and, most importantly, that the passivating hydrophobic layer is not 570 
exchanged with GL. The typical DTA signature of GL (black curve in Figure S 6e) is different 571 
than the signature of the hydrophobic coating in both as-synthesized and encapsulated UNCP 572 
samples (Figure S 6e).  573 
These experiments show that hydrophobic, aggregated, UCNPs can easily be dispersed 574 
in an aqueous environment assisted by sonication followed by exposure to GL and employing 575 
the phase change method. Absence of oleic-GL ligand exchange shown by DTA indicates that 576 
the stabilization process mainly occurs by their encapsulation in the GL vesicles, as shown by 577 
cryo-TEM (arrows 1 and 2 point at encapsulated NaYF4:Yb/Er particles in Figure 9f,g). The 578 
colloidal stability, tested here up to one hour, is impressive if compared to the control system 579 
composed of oleic acid coated UCNP in water, although less long-lasting than what we have 580 
found for iron oxide NPs. At the moment, we do not have a clear explanation for this, but the 581 
hydrophobic coating should certainly favour phase separation more than the bare surface of 582 
iron oxide NPs, and cryo-TEM data (arrow 3 in Figure 9g) also shows that it is not uncommon 583 
to find aggregated UCNP clusters outside of the vesicles.  584 
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 585 
Figure 9 – Sedimentation of static (0 rpm) GL-free and GL-encapsulated NaYF4:Yb/Ln (Ln= Er or Tm) 586 
UCNP samples measured by a) light scattering (λ= 633 nm, θ= 90°, constant shutter opening, two replica 587 
are presented) and b) photoluminescence spectroscopy (λexc= 980 nm), of which the time evolution of the 588 
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emission spectra for free sedimentation of NaYF4:Yb/Er are given in c) (nanoparticles in water) and d) 589 
(encapsulated nanoparticles). Pictures in a) correspond to irradiated (λexc= 980 nm) NaYF4:Yb/Er UCNP 590 
dispersed in GL vesicles (top picture) and cyclohexane (bottom image). e) Time evolution of the 591 
photoluminescence emission (λexc= 980 nm) of encapsulated NaYF4:Yb/Er UCNP with forced sedimentation 592 
(centrifugation at 2000 rpm). f-g) Typical cryo-TEM image of an encapsulated (arrows 1, 2) and non-593 
encapsulated (arrow 3) NaYF4:Yb/Er sample 594 
 595 
  The results presented in this work are summarized in Figure 10. Non-equilibrium 596 
entrapment of metastable functional nanoparticles can occur via the same lamellar-to-vesicle 597 
phase change process assisted by sonication. In this work, we successfully tested the 598 
encapsulation of bare (uncoated) iron oxide NPs and oleic acid coated UCNP. Iron-loaded 599 
ferritin nanocages were also encapsulated with the goal of understanding the origin of the 600 
uneven distribution of the colloids within the vesicular compartments, in comparison to the 601 
Luisi’s encapsulation experiments.13 However, these preliminary data suggest that stable 602 
colloids could also be encapsulated through the same method. As a general remark, it seems 603 
that this approach could be potentially extended to a broad class of nanocolloids both stable and 604 
unstable in water, including those bearing a hydrophobic coating. This is an interesting point 605 
compared to the literature, where efficient encapsulation in the vesicle lumen commonly 606 
requires surface stabilization of the nanoparticles via hydrophilic coatings, while hydrophobic 607 
coatings tend to partition the nanoparticles in the lipid bilayer.16,57 In terms of encapsulation 608 
efficiency, the highest standards in the literature settle around 50%, but with the clear distinction 609 
between hydrophilic and hydrophobic colloids, respectively encapsulated in the lumen and 610 
bilayer.16,57 An interesting work by Amstad et al.56 shows that iron oxide nanoparticles bearing 611 
a stable catechol-based hydrophobic coating partition in the bilayer membrane with an 612 
encapsulation efficiency of about 30%, while labile carboxylic hydrophobic induce 613 
uncontrolled NPs aggregation outside the vesicles and stable catechol-based hydrophilic 614 
coatings induce encapsulation in the lumen.  Uncoated NPs aggregates can actually be 615 
encapsulated in the lumen, but the efficiency is very low (< 10%) compared to the use of stable 616 
colloids bearing a hydrophilic coating and for which efficiency can reach 50%.60  617 
Our data collected with the phase-change method using GL show that the encapsulation 618 
efficiencies in the lumen can reach values as high as 70% on uncoated iron oxide NPs 619 
aggregates (estimated through gravimetric methods), or about 50% (after 1 h) using 620 
hydrophobic oleic acid coated UCNP (estimated with emission luminescence spectroscopy). 621 
The values settle among the highest found in the literature and they also show that the 622 
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sonication-assisted phase change method of encapsulation in the lumen can be easily applied to 623 
a broad range of as-prepared colloids, for which the classical steps involving the tedious ligand 624 
exchange process could be possibly avoided. Nonetheless, despite the fact that our data do not 625 
suggest that surface chemistry has a major impact on the vesicle-formation process from the 626 
lamellar phase above pH 4, we cannot exclude an impact on the other features, like the 627 
encapsulation efficiency, the NPs distribution within the vesicles or effects on the vesicle size 628 
and stability, as found by others.56 Furthermore, the average encapsulation efficiency found 629 
here settles around 60% with very broad variability (± 16%). It is also not excluded that the 630 
latter could be influenced by the surface chemistry of the nanocolloids but also by the process 631 
of bringing the NPs out of equilibrium through sonication, a parameter of which the role should 632 
be better explored in future work. Finally, for realistic applications, the stability of the GL 633 
vesicles in a broader pH range, especially above pH 6-7, and in cell culture media must be 634 
studied in more details. 635 
 636 
 637 
Figure 10 – NPs encapsulation into vesicles: the pH jump method used in this work start from a glucolipid 638 
solution above pH 9 (micellar) and then lowered to pH < 4 (lamellar). Sonication assists dispersion of NPs, 639 
which coexist with the micellar and lamellar phase, according to the pH value. The cartoon at pH< 4 shows 640 
that clusters of NPs coexist with the lamellar phase, although exact positioning of the clusters (intra or 641 
interlamellar) is still unclear. The lamellar-to-vesicle transition occurs above pH 4 and it is responsible for 642 
the encapsulation process, resulting a small fraction of heavily-loaded vesicles.  643 
 644 
Conclusion 645 
This paper shows the possibility to form magnetoliposomes from a biobased lipid source 646 
simply using pH as a physico-chemical trigger in water at room temperature. The vesicle-647 
forming properties of a new family of microbial glycolipids is exploited to encapsulate 648 
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magnetite (g-Fe2O3) NPs within glucolipid (GLs) vesicles. More precisely, acidic C18:1 GLs, 649 
produced by S. bombicola strain ΔugtB1 are compounds constituted by a -D-glucose 650 
headgroup linked through a glycosidic bond to the subterminal carbon (C17) of hydroxylated 651 
oleic acid, thus leaving a free-standing COOH group. As shown by SAXS and cryo-TEM, this 652 
compound mainly forms micelles at neutral to basic pH, vesicles between pH 4 and pH 6 and a 653 
lamellar phase below pH 4. Direct exploitation of the lamellar-mediated vesicle-forming 654 
mechanism when the pH is increased back from below 4 to pH 6 leads to an encapsulation of 655 
NPs simultaneously dispersed in the GL solution. Cryo-TEM shows the presence of few but 656 
densely-crowded magnetoliposomes. We have repeated the encapsulation experiment using 657 
iron-loaded ferritin (Fe4800)AfFtn and we do obtain analogous results: very few heavily loaded 658 
vesicles coexisting with empty ones. A similar distribution profile was reported for ferritin 659 
nanocages encapsulated within the lumen of liposomes obtained from standard phospholipids 660 
using more classical embedding approaches (ethanol injection, thin film hydration). The 661 
analogy between our data and the literature for the specific ferritin system suggests that the 662 
uneven distribution of NPs within vesicles found in this work does not depend on our conditions 663 
of work, but it seems to be a more general, yet misunderstood, phenomenon. 664 
In our experiments, we evaluate an encapsulation efficiency in the lumen of about 60%, 665 
a value which settles among the highest in the literature, especially if compared to the use of 666 
either uncoated or hydrophobic nanoparticles, whereas the former have shown to be 667 
encapsulated in the lumen but with efficiencies below 10% and the latter are generally 668 
encapsulated in the lipid bilayer. Nonetheless, variability is quite high (± 16%), a fact which 669 
can depend both on the surface chemistry of the NPs and, above all, on the sonication step 670 
required to bring the NPs out of equilibrium. Although at the moment it is not clear how to 671 
achieve a precise control of the encapsulation efficiency, we were able to control the average 672 
diameter between tens and several hundred of nanometers by varying the encapsulation process, 673 
still keeping the same pH change approach. Sonication was found to provide the smallest 674 
vesicle size while controlled pH change provides the largest vesicles. The extrusion 675 
experiments, besides stabilizing the average vesicle diameter around 100 nm, nicely 676 
demonstrate the high stability of the magnetoliposomes towards multiple extrusion cycles. 677 
Besides unprotected iron oxide nanoparticles, using the simple phase change 678 
encapsulation process in the presence of GL, we were able to encapsulate and stabilize two 679 
upconverting sub-50 nm nanoparticles systems composed of oleic-acid coated NaYF4:Yb/Ln 680 
(Ln= Er or Tm). These water-insoluble materials could be dispersed in water and stabilized up 681 
to 50% (according to luminescence emission spectroscopy) in the order of one hour under static 682 
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sedimentation conditions, and in the order of minutes under centrifugation at 2000 rpm. These 683 
results suggest that the present method of encapsulation in the lumen may be applied to a broad 684 
range of colloids, for which typical, but tedious, ligand exchange steps could be potentially 685 
avoided. 686 
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Supporting Information 
 
Figure captions 
 
Figure S 1 - TEM images of bare iron oxide NPs, NPs-SLs at pH 6 (NPs SL pH6, sample S5) 
and NPs- GLs at pH 9 (NPs GL pH9, sample S2). Solutions have been dried directly on the 
TEM grid before observation.  
 
Figure S 2 - a) TEM images of NPs GL samples at pH 6 (sample S3). b-d) TEM images of 
sample S4 (NPs GL, pH 2 → pH 6). Solutions are dried on the TEM grid before observation. 
The Fourier Transform (FT) performed on the rectangle-highlighted region has been denoised 
(bottom left image c)) to better put in evidence the crystalline network in the inverse FT image 
(bottom right d)). 
 
Figure S 3 - Cryo-TEM images of NPs GL samples at pH below 4 adjusted from pH 9 
 
Figure S 4 – Cryo-TEM images of a NP-free GC18 :1 solution at 0.5 w% in water at the final 
pH 6, after treating the solution at pH 9 → pH 2 → pH 6, by adding few L of 1M HCl and 
0.1 M NaOH 
 
Figure S 5 – Qualitative illustration of the encapsulation efficiencies for different batches. a) 
Control: GL vesicles in water at pH 6 next to a neodymium magnet; b) Typical image of a 
succesful encapsulation event with encapsulation efficiency lower than 50%. c) Typical image 
of a succesful encapsulation event with encapsulation efficiency higher than 50%. 
 
Figure S 6 – a) XRD, b) TEM and c) size distribution (from TEM) of NaYF4:Yb/Ln (Ln= Er or 
Tm) nanoparticle samples used in this work. d) Typical XRD pattern of NaYF4:Yb/Er 
encapsulated in GL vesicles after manual pH jump (approach 2). The sample has been freeze-
dried before characterization. e) DTA profiles of NaYF4:Yb/Er, encapsulated (in GL) 
NaYF4:Yb/Er and free GL. All NaYF4:Yb/Ln samples are stabilized by an oleic acid coating. 
